PMID: 2859580Mar 1, 1985Paper

Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia

The Psychiatric Clinics of North America
D V Sheehan

Abstract

This article reviews the evidence on the efficacy of monoamine oxidase inhibitors (MAOIs) and of alprazolam in the treatment of panic disorder and agoraphobia. It also presents guidelines to the clinician on how to implement these treatments in practice.

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.